Literature DB >> 28327992

Cyst Fluid From Cystic, Malignant Brain Tumors: A Reservoir of Nutrients, Including Growth Factor-Like Nutrients, for Tumor Cells.

Daniel Dahlberg1, Eduard A Struys2, Erwin E Jansen2, Lars Mørkrid3, Øivind Midttun4, Bjørnar Hassel5,6.   

Abstract

BACKGROUND: Brain tumors may have cysts, whose content of nutrients could influence tumor cell microenvironment and growth.
OBJECTIVE: To measure nutrients in cyst fluid from glioblastoma multiforme (GBM) and metastatic brain tumors.
METHODS: Quantification of nutrients in cyst fluid from 12 to 18 GBMs and 4 to 10 metastatic brain tumors.
RESULTS: GBM cysts contained glucose at 2.2 mmol/L (median value; range <0.8-3.5) and glutamine at 1.04 mmol/L (0.17-4.2). Lactate was 7.1 mmol/L (2.4-12.5) and correlated inversely with glucose level (r = -0.77; P < .001). Amino acids, including glutamate, varied greatly, but median values were similar to previously published serum values. Ammonia was 75 μmol/L (11-241). B vitamins were present at previously published serum values, and riboflavin, nicotinamide, pyridoxal 5΄-phosphate, and cobalamin were higher in cyst fluid than in cerebrospinal fluid. Inorganic phosphate was 1.25 mmol/L (0.34-3.44), which was >3 times higher than in ventricular cerebrospinal fluid: 0.35 mmol/L (0.22-0.66; P < .001). Tricarboxylic acid cycle intermediates were in the low micromolar range, except for citrate, which was 240 μmol/L (140-590). In cystic metastatic malignant melanomas and lung tumors values were similar to those in GBMs.
CONCLUSION: Tumor cysts may be a nutrient reservoir for brain tumors, securing tumor energy metabolism and synthesis of cell constituents. Serum is one likely source of cyst fluid nutrients. Nutrient levels in tumor cyst fluid are highly variable, which could differentially stimulate tumor growth. Cyst fluid glutamate, lactate, and phosphate may act as tumor growth factors; these compounds have previously been shown to stimulate tumor growth at concentrations found in tumor cyst fluid.
Copyright © 2016 by the Congress of Neurological Surgeons

Entities:  

Keywords:  Amino acids; B vitamins; Glioblastoma multiforme; Glucose; Inorganic phosphate; Lactate; Tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 28327992     DOI: 10.1093/neuros/nyw101

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

1.  Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Authors:  Thomas N Seyfried; Laura Shelton; Gabriel Arismendi-Morillo; Miriam Kalamian; Ahmed Elsakka; Joseph Maroon; Purna Mukherjee
Journal:  Neurochem Res       Date:  2019-04-25       Impact factor: 3.996

2.  Glioblastoma microenvironment contains multiple hormonal and non-hormonal growth-stimulating factors.

Authors:  Daniel Dahlberg; Jutta Rummel; Sonia Distante; Gustavo Antonio De Souza; Maria Ekman Stensland; Espen Mariussen; Helge Rootwelt; Øyvind Voie; Bjørnar Hassel
Journal:  Fluids Barriers CNS       Date:  2022-06-04

3.  Neurocutaneous melanosis with an intracranial cystic-solid meningeal melanoma in an adult: A case report and review of literature.

Authors:  Bo-Chuan Liu; Yu-Bo Wang; Zhuang Liu; Yan Jiao; Xian-Feng Zhang
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

4.  Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.

Authors:  Ahmed M A Elsakka; Mohamed Abdel Bary; Eman Abdelzaher; Mostafa Elnaggar; Miriam Kalamian; Purna Mukherjee; Thomas N Seyfried
Journal:  Front Nutr       Date:  2018-03-29

5.  Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic brain tumors.

Authors:  Robin Wachowiak; Matthias Krause; Steffi Mayer; Nicole Peukert; Anne Suttkus; Wolf C Müller; Martin Lacher; Jürgen Meixensberger; Ulf Nestler
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 6.  Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis.

Authors:  Christos Chinopoulos; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

7.  Assessment of ApoC1, LuzP6, C12orf75 and OCC-1 in cystic glioblastoma using MALDI-TOF mass spectrometry, immunohistochemistry and qRT-PCR.

Authors:  Petros Evangelou; Mathias Groll; Henry Oppermann; Frank Gaunitz; Christian Eisenlöffel; Wolf Müller; Klaus Eschrich; Anne Schänzer; Ulf Nestler
Journal:  Med Mol Morphol       Date:  2019-04-20       Impact factor: 2.309

8.  Pro-inflammatory cytokines in cystic glioblastoma: A quantitative study with a comparison with bacterial brain abscesses. With an MRI investigation of displacement and destruction of the brain tissue surrounding a glioblastoma.

Authors:  Bjørnar Hassel; Pitt Niehusmann; Bente Halvorsen; Daniel Dahlberg
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

Review 9.  Metabolic management of microenvironment acidity in glioblastoma.

Authors:  Thomas N Seyfried; Gabriel Arismendi-Morillo; Giulio Zuccoli; Derek C Lee; Tomas Duraj; Ahmed M Elsakka; Joseph C Maroon; Purna Mukherjee; Linh Ta; Laura Shelton; Dominic D'Agostino; Michael Kiebish; Christos Chinopoulos
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

10.  Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care.

Authors:  Lee Curtin; Paula Whitmire; Cassandra R Rickertsen; Gina L Mazza; Peter Canoll; Sandra K Johnston; Maciej M Mrugala; Kristin R Swanson; Leland S Hu
Journal:  Front Oncol       Date:  2020-11-16       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.